Background: Although different studies associated sleep deprivation (SD) with systemic inflammatory changes, the effect of sleep duration on the pathology of allergic chronic diseases is poorly understood. Objective: We sought to evaluate the influence of SD on allergen-induced pulmonary inflammation. Methods: Ovalbumin (OVA)-sensitized C57BL/6 mice were exposed to a first set of intranasal OVA challenge under SD or healthy sleep (HS) conditions, followed by a second OVA challenge, 1 week apart. Some groups were subjected to corticosteroid treatment with dexamethasone. Results: OVA-sensitized mice with SD had more severe airway inflammation than the allergic group with HS. Analysis of lung parenchyma revealed that the inflammation in allergic mice with SD was marked by an influx of neutrophils (mainly) and eosinophils and secretion of IL-6, TNF-a, and IL-17 in contrast to the eosinophilic inflammation and IL-4 production observed in allergic mice with HS. The same cytokine profile was observed in ex vivo culture of cervical lymph node cells and splenocytes, indicating that in allergic mice SD favors immune responses toward a proinflammatory T H 17 profile. This idea is supported by the fact that disruption of IL-17 signaling (IL-17 receptor A 2/2 ) prevented airway neutrophilia in allergic mice with SD. Furthermore, allergic mice with SD became refractory
Asthma is a complex chronic disease that affects around 235 million persons worldwide.
1 Asthma pathology was first described as a T H 2 disorder characterized by intermittent airway hyperresponsiveness, eosinophilic airway inflammation, mucus hypersecretion, and high IgE levels. However, evidence from clinical practice demonstrated that asthma is a heterogeneous disorder that presents several phenotypes that vary from mild/moderate to severe manifestations. According to the spectrum of the inflammatory response found in patients, asthma severity has been classified as mild/moderate, which is manifested by minimal or prominent eosinophilic inflammation, and moderate/severe, with predominant neutrophilic or mixed granulocytic inflammation. 2, 3 Furthermore, a recent study demonstrated that T H 2/T H 17 cells and IL-17 were present at a higher frequency in the bronchoalveolar lavage fluid (BALF) of patients with severe asthma and that these cells were resistant to dexamethasone-induced cell death. 4 Allergens play an important role in asthma severity, but the subjects' genetic and epigenetic variability mediated by several environmental factors can contribute to asthma exacerbation. 5 In this regard, recent studies have investigated the relationship between sleep quality and asthma. [6] [7] [8] Indeed, there is an association between sleep quality and asthma morbidity in children. 9 Sleep quality is important in many aspects of immune system homeostasis. 10 A night of wakefulness or 5 days of sleep restriction alter the T H 1/T H 2 balance. 11, 12 Because it has been described that sleep deprivation (SD) results in a nonspecific production of inflammatory cytokines with marked neutrophilia, 10, [13] [14] [15] [16] we hypothesized that SD could be a risk factor for the development of neutrophilic asthma in allergic subjects. Hence our goal was to determine the influence of sleep duration on the outcome of allergic inflammation. Specifically, we used the ovalbumin (OVA)-allergic lung inflammation model associated with SD and compared this with allergic mice with healthy sleep (HS). We show that allergic mice with SD had a mixed, IL-17 dependent, granulocytic inflammatory response with predominant neutrophilic infiltration and also became refractory to corticosteroid treatment. Hence we present experimental data that support the idea that sleep can play a role in the progression of mild/moderate allergic inflammation toward a more severe neutrophilic manifestation.
METHODS Mice
Male C57BL/6 wild-type (WT), OT-II-transgenic and CD4-deficient mice at 6 to 8 weeks of age, were obtained from Centro de Desenvolvimento de Modelos Experimentais para Medicina e Biologia, Federal University of São Paulo. IL-17 receptor (IL-17RA) deficient mice were obtained from Ribeirão Preto Medical School, University of São Paulo. Mice were housed under specific pathogen-free conditions at the Division of Immunology facility, Federal University of São Paulo. All animal protocols used in this study were approved by the Federal University of São Paulo Animal Care and Use Committee under protocol number 3919250314 and were in accordance with the recommendations of Federal Law 11.794 (2008) and the ''Guide for the care and use of laboratory animals'' of the Brazilian National Council of Animal Experimentation. All protocols and animal care and handling strictly followed the National Institutes of Health ''Guide for the care and use of laboratory animals'' (publication no. 85-23, revised 1985).
Immunization and airway inflammation protocol
Mice were treated with OVA, as described previously, 17 with modifications. Briefly, mice were sensitized on days 0 and 7 with 10 mg of OVA (grade V; Sigma-Aldrich, St Louis, Mo) in 1.6 mg of aluminum hydroxide (Sigma-Aldrich) diluted in PBS (0.4 mL). On days 14, 15, 16, 24, 25 , and 26, mice were challenged intranasally with OVA (10 mg) in PBS (50 mL) after brief anesthesia with a mixture of 5% isoflurane and 30% oxygen. 18 Control mice were sensitized and challenged with PBS. On day 27, mice were euthanized, and samples were collected for further analysis. For corticosteroid treatment, allergic mice received daily dexamethasone intraperitoneal injections (5 mg/kg) 6 hours after OVA challenges on days 24, 25, and 26.
SD protocol
Mice were submitted to SD for 72 hours during the first OVA challenge (days 14, 15, and 16) by using the modified multiple-platform method. 19, 20 This method consists of placing 6 animals in a ventilated polycarbonate cage (38 3 31 3 17 cm) containing 12 circular platforms (3.5 cm in diameter) surrounded by water up to 1 cm beneath the surface. The animals are able to move inside the cage, jumping from one platform to the other. All mice underwent a period of training to stay on the platform before the experimental proceedings of SD to attenuate the stress inherent to the protocol. This training consisted of remaining on the platforms in a box with water for 3 hours for 3 consecutive days before initiation of the SD protocol. When animals reach the paradoxical (rapid eye movement [REM]) phase of sleep, they are awakened when their faces touch the water as a result of muscle atony. Previous studies in mice demonstrated that the multiple-platform method completely abolished paradoxical sleep (REM) during the deprivation period but also resulted in a mild reduction (30%) in slow-wave sleep. Thus mice can sleep about 70% of the non-REM sleep in the platforms. 21, 22 The water in the cage was changed daily at 10 AM, when the mice were moved to a dry cage for a few minutes. Food and water were available ad libitum throughout the SD period. The control non-sleep-deprived groups (HS groups) were maintained in the same ventilated rack system. All mice were kept in 12-hour/12-hour light-dark cycles (lights on at 7 AM) to avoid circadian alterations.
BALF
Mice were deeply anesthetized by intraperitoneal injection of a solution containing ketamine (0.1 g/mL) and xylazine (0.02 g/mL). Tracheas were cannulated, and lungs were washed 3 times with 0.5 mL of PBS. Total and differential BALF cell counts were determined by using cytospin preparations.
Flow cytometry
Analysis of the cellular profile in the lungs, spleens, and lymph nodes was performed by using flow cytometry. Briefly, after BALF collection, lungs were perfused with 10 mL of cold PBS and removed. Lungs were minced and treated with RPMI 1640 (Gibco, Carlsbad, Calif) containing 1 mg/mL DNAse and 2 mg/mL collagenase (Sigma-Aldrich) for 20 minutes at 378C. After centrifugation, cells were submitted to a Percoll gradient. 23 Single-cell suspensions from spleens and lymph nodes were obtained by dissociation with a cell strainer and red blood cell lysis with ACK solution (0.15 mol/L NH 4 Cl, 1 mmol/L KHCO 3 , and 0.1 mmol/L Na 2 EDTA). Cells were washed in RPMI 1640 (Gibco), and viability was evaluated with 0.2% Trypan Blue exclusion dye to discriminate between live and dead cells. One million cells were cultured for 6 hours in the presence of phorbol 12-myristate 13-acetate (20 ng/mL, Sigma), ionomycin (1 mg/mL, Sigma), and brefeldin (GolgiPlug; BD PharMingen) to assess intracellular cytokine production. Subsequently, cells were processed with Cytofix/ Cytoperm (BD PharMingen), according to the manufacturer's instructions, and stained with the following antibodies: CD45 Pacific Blue (clone 3D-F11), CD3 APC-Cy7 (clone 145-2C11), CD4 PerCP (clone RM4-5), IFN-g APC (clone XMG1.2), TNF-a PE-Cy7 (clone MP6-XT22), IL-17 PE (clone TC11-18H10), IL-6 FITC (clone MP5-20F3), F4/80 PE (clone BM8), Gr1 Pacific Blue (clone RB6-8C5), and CD11b APC-Cy7 (clone M1/70). One million events in a live lymphocyte gate were acquired on a FACSCanto II flow cytometer (BD Biosciences) and then analyzed with FlowJo software (version 10; TreeStar, San Carlos, Calif). In addition, we used the Boolean gate platform to create several combinations of cytokine-producing cells, resulting in distinct patterns. The frequency of cytokine-producing cells was calculated by subtracting background values. For each flow cytometry experiment performed in this study, unstained and all single-color controls were processed to allow proper compensation.
Sorting and adoptive transfer of CD4
1 T cells
Transgenic OT-II mice were sensitized and challenged with 10 mg of OVA (323-339) MHC class II-restricted peptide (ISQAVHAAHAEINEAGR; GenScript, Piscataway, NJ). OT-II mice were distributed into 2 groups, and one group was sleep deprived between days 14 and 16. Twenty-four hours after the last challenge (day 17), spleens of OT-II mice were collected, and CD4
1 T cells were purified by using fluorescence-activated cell sorting, after which 1.5 3 10 6 cells were adoptively transferred intravenously to CD4-deficient mice (CD4 knockout [KO] ). CD4 KO mice were then challenged, as previously described, and 24 hours after the last challenge, mice were euthanized.
Cell culture
Cells from spleens, cervical lymph nodes (CLNs), and lungs were isolated, as described previously, and cultured (1 3 10 6 /200 mL) for 3 days in RPMI 1640 supplemented with 10% FBS (Gibco), 2 mmol/L L-glutamine (Gibco), 10 mmol/L HEPES (Gibco), 1 mmol/L sodium pyruvate (Gibco), 1% vol/vol nonessential amino acid solution (Gibco), 40 mg/mL gentamicin, 20 mg/mL Ciprofloxacin (isofarma, Eus ebio, Brazil) and 5 3 10 25 mol/L 2-mercaptoetanol (Gibco) in the presence of OVA (10 mg/mL). After the incubation period, 150 mL of the supernatants was collected and frozen at 2208C until cytokine quantification.
Cytokine determination
Mouse cytokines in culture supernatants were detected simultaneously by using the mouse T H 1/T H 2/T H 17 cytokine Cytometric Bead Array Kit (BD PharMingen), according to the manufacturer's instructions. Cytokines in serum samples (IL-4, IL-5, and IL-13) were evaluated with ELISA Ready-SET-Go! Kits (eBioscience, San Diego, Calif).
OVA-specific IgG 1 and IgE determination
Ninety-six-well High Binding plates (Corning, NY) were coated with 20 mg of OVA (grade II; Sigma-Aldrich) diluted in PBS overnight. After (Fig 1, C) , neutrophil (Fig 1, D) , and eosinophil (Fig 1, E) counts of cytospin preparations from BALF cells. F-I, Frequency of neutrophils (Fig 1,  F) , eosinophils (Fig 1, G) , mast cells (Fig 1, H) , and basophils (Fig 1, I ) in the lung determined by using flow cytometry. Data were from 3 independent experiments (n 5 5-8 mice per group). Only significant differences between the HS and SD allergic groups are shown. ***P < .001 and ****P < .0001.
washing with PBS-0.02% Tween 20 (PBST), wells were blocked with 5% nonfat milk and 1% BSA in PBST for 2 hours at room temperature (RT). After this period, the plates were washed with PBST and incubated with mouse serum for 1 hour at RT. Plates were washed with PBST and incubated with horseradish peroxidase anti-mouse IgG 1 (SouthernBiotech, Birmingham, Ala) for 2 hours at RT. After washing with PBST, the enzymatic reaction was developed by the addition of 1 mg/mL o-phenylenediamine (Sigma) diluted in phosphate-citrate buffer, pH 5.0, containing 0.03% (vol/vol) hydrogen peroxide. The enzymatic reaction was stopped by addition of 50 mL of a solution containing 4N H 2 SO 4 . Plates were read at 492 nm (OD 492 ) (Thermofisher Scientific, Waltham, Mass). Anti-OVA-specific IgE levels were measured with the mouse anti-OVA IgE ELISA Kit (Cayman Chemical, Ann Arbor, Mich), according to the manufacturer's instructions.
Corticosterone quantification
Plasma corticosterone levels were assessed by using ultrafast liquid chromatography-tandem mass spectrometry. 24 All sample analyses were performed on a Quattro Micro triple quadrupole mass spectrometer (Waters, Milford, Mass) by using a Kinetex (50 3 2.10 mm, 2.6 mm) column at a flow rate of 0.2 mL/min, which was controlled by using MassLynx 4.1 software (Waters). The lower quantification limit for corticosterone was 10 ng/mL.
Data analysis
One-way ANOVA followed by the Tukey honestly significantly difference or unpaired t test were used to compare the possible differences between groups. Statistical analysis and graphic representation of data were performed by using GraphPad Prism version 7.0 software (GraphPad Software, La Jolla, Calif). Significance was accepted at an a value of .05.
RESULTS

SD exacerbates airways and lung inflammation in allergic mice
Mice were sensitized with OVA adsorbed to alum and challenged with OVA intranasally (on days 14, 15, and 16 and 24, 25, and 26) to induce airway inflammation to investigate the effect of SD in allergic lung inflammation. One group of mice was sleep deprived for 72 hours during the first round of OVA challenge, as outlined in Fig 1, A. After the last set of OVA challenges, allergic mice with HS presented significant airway inflammation, which was increased approximately 2-fold by SD (Fig 1, B) . Notably, the exacerbated inflammatory response in allergic mice with SD was characterized by a significant influx of mononuclear cells (Fig 1, C) with a predominant neutrophilic BALF inflammation (Fig 1, D) . In contrast, allergic mice with HS presented with airway eosinophilia (Fig 1, E) .
Consistent with the BALF findings, analysis of lung parenchyma by flow cytometry showed a significant increase in the frequency of eosinophils in allergic mice with HS (Fig  1, F) . The allergic group with SD presented an influx of neutrophils and mast cells into the lung parenchyma, supporting the idea that sleep duration influences the pattern of the inflammatory reaction in allergic mice (Fig 1, G and H,  respectively) . Although basophil numbers were increased both in the HS and SD allergic groups, no significant difference was observed between these groups (Fig 1, I ).
FIG 2. SD induces a proinflammatory T H 17 profile.
A, TNF-a, IL-4, IL-6, and IL-17 levels in culture supernatant from lungs, CLNs, and spleen cells were assessed by using a Cytometric Bead Array. B, IL-4, IL-5, and IL-13 levels in serum were assessed by ELISA. Data were from 3 independent experiments (n 5 5-8 mice per group). Only significant differences between the HS and SD allergic groups are shown. **P < .01, ***P < .001, and ****P < .0001. ND, Not detected.
SD drives the cytokine profile to a pro-T H 17 pattern
Next, we evaluated the cytokine profile of culture supernatants after cells were stimulated in vitro with OVA. Fig 2 shows that lung cells from allergic mice with SD produced higher levels of IL-17 and IL-6, which was in contrast to those from the allergic group with HS, in which IL-4 production was higher. A similar cytokine profile was observed in CLNs and spleen cells from allergic mice with HS and SD, corroborating the idea that SD influences the allergen-induced immune response pattern. Also, SD led to a higher secretion of TNF-a by lung cells, whereas it did not affect TNF-a production by CLNs or spleen cells. When we analyzed cytokine content in . Only significant differences between the HS and SD allergic groups are shown. *P < .05, **P < .01, and ***P < .001.
= FIG 4. SD aggravates allergen-induced lung inflammation in an IL-17RA-dependent manner.
A, Total BALF cell counts. B and C, Eosinophil (Fig 4, B) and neutrophil (Fig 4, C) counts of cytospin preparations from BALF cells. D and E, Frequency of eosinophils (Fig 4, D) and neutrophils (Fig 4, E) in the lungs determined by using flow cytometry. Data were from 2 independent experiments (n 5 6 mice per group). Only significant differences between the HS and SD allergic groups are shown. **P < .01 and ***P < .001. White bars, WT mice; black bars, IL-17RA-deficient mice (IL-17RA
2/2
).
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 3 serum (Fig 2, B) , we observed higher amounts of IL-4 and IL-13 in serum from allergic mice with SD when compared with the allergic group with HS, whereas no difference was observed in IL-5 levels. Despite the influence of SD in local and systemic cytokine profiles, B-cell responses did not seem to be modulated by sleep duration because antibody production, which was marked by high levels of anti-OVA IgG 1 and IgE, was similar in both allergic mice with HS and those with SD (see Fig E2 in this article' s Online Repository at www.jacionline.org).
SD potentiates migration of T H 17-comitted CD4
1
T cells to the lungs
The results described above demonstrated that SD favors the development of a pro-T H 17 environment. Analysis of intracellular cytokine content (Fig 3, A) revealed that lungs from allergic mice with SD presented a higher frequency of IL-17 and TNF-a but not of IFN-g-producing CD4
1 T cells in comparison with the allergic group with HS. Boolean combinations of cytokine-producing CD4 1 T cells indicated that allergic mice with SD had a higher percentage of polyfunctional IL-17
1 /TNF-a 1 T cells. Similarly, the frequency of IL-6
1 and TNF-a 1 producing macrophages was higher in allergic mice subjected to SD than in the HS group (Fig 3, B) . We also observed a higher frequency of IL-6 1 /TNF-a 1 double-positive macrophages in the lungs of allergic mice with SD. Notably, polyfunctional cells produced larger amounts of each cytokine than single cytokine-producing cells, as determined based on median fluorescence intensity (data not shown). Thus SD predisposes allergic mice to a more inflammatory allergen-induced airway reaction marked by high levels of IL-17, IL-6, and TNF-a.
Next, CD4-deficient recipient mice (CD4 KO) were adoptively transferred with purified CD4 1 T cells from OT-II-transgenic OVA-sensitized animals submitted to HS or SD regimens, as outlined in Fig 3, C. Airway inflammation, more specifically neutrophilia, was 3-fold greater in the CD4 KO mice that received CD4 1 T cells from allergic mice with SD when compared with the group that received cells from allergic mice with HS (Fig 3, D and E) . Furthermore, the lung parenchyma of CD4 KO mice transferred with CD4 1 T cells from the allergic group with SD displayed a higher neutrophil frequency (Fig 3, F) . Thus SD increases production of inflammatory mediators committed with neutrophilic inflammation, which aggravates the pulmonary reaction in response to airborne antigens.
IL-17 signaling is essential for allergen-induced neutrophilic inflammation associated with SD
To evaluate whether OVA-induced neutrophilic inflammation observed in the allergic mice with SD was mediated by IL-17 signaling itself or by another product of T H 17 cells, we used IL-17RA deficient mice (IL-17RA 2/2 ). In contrast to WT mice, IL-17RA 2/2 allergic mice subjected to SD did not display exacerbated airway inflammation in BALF when compared with the allergic group with HS (Fig 4, A) . IL-17RA 2/2 allergic mice with SD presented higher numbers of eosinophils and impaired airway neutrophilia in contrast to the WT allergic group (Fig 4,  B and C) . Consistent with the BALF findings, the lung parenchyma of IL-17RA 2/2 allergic mice with SD was mainly composed of eosinophils (Fig 4, D and E) . Our data show that during allergen-induced inflammation, IL-17 signaling is essential for neutrophil recruitment into the lungs on SD.
SD induces corticosteroid resistance in allergic mice
In addition to neutrophilic inflammation, the resistance to steroid therapy is another hallmark of allergic diseases. 5, 25 Both allergic mice with HS and those with SD received daily dexamethasone treatment during the last set of airway OVA challenge to determine the influence of sleep duration in the setting of corticosteroid resistance. Corticosteroid treatment inhibited the influx of cells, more specifically eosinophils and neutrophils, to the airways of both the HS and SD allergic groups (Fig 5, A-C) . However, in allergic mice with SD, dexamethasone administration did not modulate production of IL-17 and TNF-a by lung cells, indicating that the inflammatory response in allergic mice with SD is more resistant to corticosteroid effect (Fig 5, D  and E) . No difference was observed in IL-6 levels (Fig 5, F) . In addition, SD also influenced the pulmonary inflammatory pattern. We also observed that allergic mice with SD presented a persistent peribronchovascular infiltration in contrast to the HS allergic group (Fig 5, G) .
DISCUSSION
Sleep quality exerts an important influence on host immune system homeostasis. However, its effect in the setting of chronic allergic diseases remains elusive. The present study demonstrates that SD is associated with increased IL-17 levels, lung neutrophilia, and resistance to corticosteroid treatment.
Because asthmatic patients experience disturbed sleep periods due to breathlessness, nighttime coughing, and wheezing, the disease itself impairs sleep quality, which can be implicated in further complications. 6 For example, immunity against pathogens and the efficacy of vaccination are impaired by SD or sleep restriction. 26, 27 This phenomenon seems to be associated with a shift toward T H 2 responses, impairing protective T H 1 immunity.
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In the first set of experiments, it was possible to observe that allergic mice subjected to SD had intense mixed granulocytic inflammation with prevalence of neutrophils. The allergeninduced T H response was marked by TNF-a and IL-17 production, which is in contrast to that observed in allergic mice with HS, in which pulmonary inflammation was marked by eosinophils and IL-4. However, in serum, allergic mice with SD presented higher levels of IL-4 and IL-13 than allergic mice FIG 5 . SD induces corticosteroid resistance in allergic mice. A, Total BALF cell counts. B and C, Eosinophil (Fig 5, B) and neutrophil (Fig 5, C) counts of cytospin preparations from BALF cells. D-F, IL-17 (Fig 5, D) , TNF-a (Fig 5, E) , and IL-6 (Fig 5, F) levels in culture supernatants from lung cells were assessed by using the Cytometric Bead Array. G, Representative lung section stained with hematoxylin and eosin for analysis of cellular inflammation (original magnification 3200). Data were from 2 independent experiments (n 5 6 mice per group). DEXA, Dexamethasone. Only significant differences between the vehicle and dexamethasone treated groups are shown. *P < .05, **P < .01, and ****P <.0001. White bars, Vehicle-treated mice; black bars, dexamethasone-treated mice. It has been demonstrated that SD could itself increase the levels of inflammatory markers, such as IL-6, TNF-a, and IL-17, and systemic neutrophilia. [29] [30] [31] [32] Indeed, when euthanasia was performed 24 hours after SD, nonallergic mice had more neutrophils in the airways than mice with HS (see Fig E3 in this article's Online Repository at www.jacionline.org). In addition, SD concomitant to allergen exposure affected the development of OVA-specific inflammatory responses, favoring airway neutrophilia and the development of long-lasting OVA-specific T H 17 cells in the lung.
To better understand the effect of SD in the specific CD4
1
T-cell response, we adoptively transferred CD4 1 T lymphocytes from immunized OT-II OVA-transgenic mice to CD4-deficient mice (CD4 KO). CD4
1 T-cell transfer from SD OT-II mice to CD4 KO resulted in a 3-fold increase in BALF and lung inflammation when compared with that seen in CD4 KO mice transferred with CD4 1 T cells from the HS group. Thus SD altered the proinflammatory potential of effector CD4 1 T lymphocytes.
Our data suggest that SD predisposes allergic mice to respond to allergen stimulation with neutrophilic inflammation and increased IL-6, TNF-a, and IL-17 levels. Because IL-17 is implicated in lung neutrophilia, 33, 34 we then studied the effect of SD in IL-17RA deficient mice. In contrast to what was observed in WT allergic mice, IL-17RA 2/2 allergic animals subjected to SD did not have more intense airway or lung inflammatory responses when compared with allergic animals with HS, further supporting a key role for IL-17 in lung neutrophilia. In addition, the inverse correlation between eosinophils/neutrophils detected in WT mice was not observed in IL-17RA 2/2 mice. There was no significant difference in eosinophil numbers in IL-17RA 2/2 mice compared with those in the HS and SD allergic groups. This observation is in line with previous work that demonstrated that IL-17 signaling attenuated allergen-induced airway eosinophilia. 35 Indeed, treatment with anti-IL-17R mAb (brodalumab) showed positive results in a subgroup of patients with moderate/severe asthma, whereas no efficacy/evidence of effect was observed in the overall study population. 36 Severe asthma characterized by neutrophilia is often resistant to corticosteroid treatment, 37, 38 and IL-17 is associated with the resistance observed in patients with severe asthma. 39 In animal models, transfer of effector T H 17 cells to sensitized mice resulted in neutrophil migration into the lung that was not inhibited by dexamethasone, which was in contrast to the suppression of lung eosinophilia that resulted from T H 2 cells. 40 In our model dexamethasone treatment completely abrogated airway eosinophilia in either the SD or HS allergic groups. However, neutrophil influx into the airways of the allergic group with SD was only partially inhibited by corticosteroid treatment. Also, dexamethasone treatment did not suppress IL-17 production, suggesting that corticosteroid effects on neutrophilia might be due to its effect in granulopoiesis 41, 42 or secretion of CXC chemokines, such as cytokine-induced neutrophil chemoattractant (CXCL1), macrophage inflammatory protein 2 (CXCL2), or both. 43 Because the resistance of T H 17 cells to dexamethasone has been described in both experimental and clinical settings, [44] [45] [46] it is possible to associate decreased neutrophilia and persistent IL-17 levels. Indeed, a recent study suggests a combination of dexamethasone and anti-IL-17 treatment to alleviate steroid-insensitive asthma. 47 Taken together, our findings support the idea that SD constitutes a risk factor for the evolution of mild/moderate asthma toward the moderate/severe phenotype. Although the mechanisms underlying SD-induced development of a neutrophilic corticosteroid-resistant T H 17 pattern in the allergic group remain elusive, recent studies demonstrated that neutrophil recruitment to the lung, T H 17 commitment, and resistance to corticosteroids are under regulation of the circadian clock. 48, 49 Thus it is conceivable that alterations in sleep regimens modulate the development of adaptive responses in allergic subjects. Although it might not be possible to completely extricate sleep loss from general stress effects, we did not observe a significant difference in corticosterone levels between the HS and SD allergic groups (see Fig E4 in this article' s Online Repository at www.jacionline.org).
In conclusion, sleep disturbance because of asthma symptoms might exert a deleterious influence on allergic subjects. In addition to common therapeutics, monitoring sleep quality in allergic subjects seems to constitute an important tool for the management of asthma pathology. OVA-specific IgG 1 (A) and IgE (B) levels were assessed by ELISA. Data were from 3 independent experiments (n 5 6 mice per group).
FIG E3
. SD aggravates allergen-induced airway inflammation. A, Experimental protocol. i.n., Intranasal; s.c., subcutaneous. B, Total BALF cell counts. C-E, Differential counts of cytospin preparations from BALF cells. F-I, Frequency of myeloid cell subsets in the lung, as determined by using flow cytometry. J, TNF-a, IL-4, IL-6, and IL-17 levels in culture supernatants from lungs cells were assessed by using a Cytometric Bead Array. Data were from 3 independent experiments (n 5 5-8 mice per group). Only significant differences between the HS and SD groups and between the HS and SD allergic groups are shown. **P < .01, ***P < .001, and ****P <.0001.
FIG E4
. SD did not influence corticosterone levels. Corticosterone levels in plasma were assessed by using liquid chromatography tandem mass spectrometry 24 hours after the last set of OVA challenges.
